A Chinese-based biotech company’s investigational new drug application (IND) was given the nod by the U.S. Food and Drug Administration (FDA), meaning that Alphamab Oncology…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.